26759-48-8

Usage

InChI:InChI=1/C12H14O5S/c1-15-8-4-7-10(5-9(8)16-2)18-6-12(7,14)11(13)17-3/h4-5,14H,6H2,1-3H3

Upstream product

• 26759-47-7 methyl 2-(carbomethoxymethylthio)-4,5-dimethoxy-benzoate 
• 26791-94-6 2-carboxymethylsulfanyl-4,5-dimethoxy-benzoic acid 

Downstream Products

• 809235-74-3 3-(3-bromo-benzyloxy)-5,6-dimethoxy-benzo[b]thiophene-2-carboxylic acid methyl ester 
• 26759-49-9 methyl 3,5,6-trimethoxybenzo[b]thiophene-2-carboxylate 
• 809235-72-1 5,6-dimethoxy-3-phenethyloxy-benzo[b]thiophene-2-carboxylic acid 
• 809235-75-4 3-(3-bromo-benzyloxy)-5,6-dimethoxy-benzo[b]thiophene-2-carboxylic acid 
• 809235-71-0 5,6-dimethoxy-3-phenethyloxy-benzo[b]thiophene-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

CYCLOALKYL AND HETEROCYCLOALKYL SUBSTITUTED BENZOTHIOPHENES AS THERAPEUTIC AGENTS

The present invention provides benzo[b]thiophenes of Formula (I) wherein R1, R2, R3, and L have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as age

3-ARYLOXY AND 3-HETEROARYLOXY SUBSTITUTED BENZO(B) THIOPHENES AS THERAPEUTIC AGENTS WITH PI3K ACTIVITY

The present invention provides benzo[b]thiophenes of Formula (I), wherein R1, R2, R3, R4, R5, and L have any of the values defined therefor in the specification, and pharmaceutically acceptable salts

PHARMACEUTICAL COMPOUNDS

Compounds of the formula: STR1 in which each R 1 is hydrogen, C 1-4 alkyl, C 1-4 alkoxy, halogen or nitro, and n is 0, 1, 2 or 3, R 2 is hydrogen, C 1-4 alkyl or C 2-4 alkenyl, R. sup.3 and R. sup.4 are each hydrogen, C 1-4 alkyl, optionally substituted phenyl or C. sub.6-9 cycloalkyl optionally substituted by 1 to 4 C 1-4 alkyl groups, R 5 is optionally substituted phenyl, tetrahydronaphthyl, phthalimido, saccharinyl, glutaramido, C 6-10 cycloalkyl optionally substituted with 1 to 4 C. sub.1-4 alkyl groups or a phenyl group, or C. sub.4-9 heterosubstituted cycloalkyl optionally substituted with 1 to 4 alkyl groups, x is 1, 2 or 3, y is 0 or 1 and z is 0, 1, 2 or 3; and salts thereof.The compounds are indicated for use in the treatment of disorders of the central nervous system.

Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents

The synthesis and antiallergic activity of a series of novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles are described. A number of the compounds inhibit the release of histamine from anti-IgE stimulated basophils obtained from alle

3-Alkoxy-thianapthene-2-carboxamides

The 3-alkoxy-thianaphthene-2-carboxamides of this invention are effective for the treatment of mammals afflicted with emesis. When administered to dogs in dosages of 250 μg/kg, compounds of this invention give 100% protection against vomiting normally induced by subcutaneous administration of apomorphine. The compounds of this invention also favorably modify behavior disturbances in mammals.